CAS: 70-07-5; 5-((2-Methoxyphenoxy)Methyl)Oxazolidin-2-One

该化合物是一种被归类为肌肉放松剂的化学化合物,主要用于其止痛性能;它是被称为苯氧新诺明的化合物类别的一部分;该物质具有缓解肌肉抽搐和不适的能力,在各种治疗应用中有用;该物质具有中度亲脂性,影响体内的吸收和分布;该物质一般是口服,在肝脏中代谢,其影响归因于其对...

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号60420-27-1 3-propionyl-2-o... | CAS号870-63-3 1-溴-3-甲基-2-丁烯 | CAS号124-38-9 二氧化碳 | CAS号590-28-3 氰酸钾 | CAS号93-14-1 愈创甘油醚 | CAS号57-13-6 尿素 | CAS号153756-96-8 4-acetamidophen... | CAS号366789-02-8 利伐沙班 | CAS号77943-39-6 (4R,5S)-(+)-4-甲... | CAS号104-21-2 乙酸大茴香酯

合成工艺路线路线简述

    愈创甘油醚,尿素 反应 5.0H,反应生成 美芬诺酮
    参考文献:5-Aryloxymethyl-2-Oxazolidinones
    标题:5-Aryloxymethyl-2-Oxazolidinones
    摘要:
    DOI:10.1021/ja01490A037

    海关参考信息

    专利信息


    专利号:US-6794534-B2
    优先权日:2000-06-23
    标题:Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
    发明人:GRUBBS ROBERT H; CHATTERJEE ARNAB K; MORGAN JOHN P; SCHOLL MATTHIAS; CHOI TAE-LIM
    权利人:CALIFORNIA INST OF TECHN
    摘要:The invention is directed to the cross-metathesis and ring-closing metathesis reactions between geminal disubstituted olefins and terminal olefins, wherein the reaction employs a Ruthenium or Osmium metal carbene complex. Specifically, the invention relates to the synthesis of α-functionalized or unfunctionalized olefins via intermolecular cross-metathesis and intramolecular ring-closing metathesis using a ruthenium alkylidene complex. The catalysts preferably used in the invention are of the general formula n wherein: n M is ruthenium or osmium; n X and X 1 are each independently an anionic ligand; n L is a neutral electron donor ligand; and, n R, R 1 R 6 , R 7 , R 8 , and R 9 are each independently hydrogen or a substituent selected from the group consisting of C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, aryl, C 1 -C 20 carboxylate, C 1 -C 20 alkoxy, C 2 -C 20 alkenyloxy, C 2 -C 20 alkynyloxy, aryloxy, C 2 -C 20 alkoxycarbonyl, C 1 -C 20 alkylthio, C 1 -C 20 alkylsulfonyl and C 1 -C 20 alkylsulfinyl.

    专利号:US-7420052-B2
    优先权日:2001-08-24
    标 题:Intermediates for synthesis of vinblastine, process for preparation of the intermediates and process for synthesis of vinblastines
    发明人:FUKUYAMA TOHRU; TOKUYAMA HIDETOSHI; YOKOSHIMA SATOSHI
    权利人:JAPAN SCIENCE & TECH AGENCY
    摘要:An intermediate for vinblastine synthesis represented by general formula A. n ngeneral formula A.n n(in the formula, R 1 , R 2 , R 3 and R 4 are the group selected independently from the group consisting of H, lower alkyl group, lower alkoxy group, halogen, lower perfluoroalkyl group, lower alkylthio group, hydroxy group, amino group, mono- or di-alkyl or acylamino group, lower alkyl or arylsulfonyloxy group. R 5 is H, or a lower alkyl group or a substituted or non-substituted aryl group, R 6 is an alkyl group of carbon number 4 or less, R 7 is a substituted or non-substituted aryl group, R 8 is a substituted or non-substituted aryl group or lower alkyl group and R 9 is an acyl group or trialkylsilyl group.) A method for synthesis of the compound of general formula A utilizing radical ring forming reaction of thioanilides and using the compound of general formula B as the starting material, synthesizing thioanilide of general formula C by the reaction with compound 1 and the formation of a 11-membered ring by intramolecular alkylation of 2-nitrobenzenesulfonamide by which the reactions can proceed under mild conditions and high yield can be accomplished.

    专利号:US-7825244-B2
    优先权日:2005-06-10
    标题:Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
    发明人:BAINDUR NAND; GAUL MICHAEL DAVID; KREUTTER KEVIN DOUGLAS; XU GUOZHANG
    权利人:JANSSEN PHARMACEUTICA NV
    摘要:The invention is directed to alkylquinoline and alkylquinazoline compounds of Formula C: n nwherein R 1 , R 2 , R 99 , and X are as defined herein, the use of such compounds in the synthesis of protein tyrosine kinase inhibitors, particularly inhibitors of FLT3 and/or c-kit and/or TrkB.

    专利号:WO-9517903-A1
    优先权日:1993-12-28
    标 题:Modular design and synthesis of oxazolone-derived molecules
    发明人:HOGAN JOSEPH C JR; CASEBIER DAVID; FURTH PAUL; TU CHENG
    权利人:ARQULE PARTNERS L P; HOGAN JOSEPH C JR; CASEBIER DAVID; FURTH PAUL; TU CHENG
    摘要:The design and synthesis of novel oxazolone-derived molecular modules and the use of the modules in the construction of new molecules and fabricated materials is disclosed. The new molecules and fabricated materials are molecular recognition agents useful in the design and synthesis of drugs, and have applications in separations and materials science.

    专利号:WO-2005051933-A1
    优先权日:2003-11-28
    标题 :An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
    发明人:KUMAR YATENDRA; KAUL VIJAY KUMAR; SINGH NITU; YADAV GYAN CHAND
    权利人:RANBAXY LAB LTD; KUMAR YATENDRA; KAUL VIJAY KUMAR; SINGH NITU; YADAV GYAN CHAND
    摘要:Provided herein are process for the synthesis of the 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, which is a key intermediate in the synthesis of oxazolidinone compounds having antibacterial activity. Also provided herein are processes for preparing oxazolidinone compounds. In addition, compounds prepared by the processes provided herein are also encompassed. Formula (I) and Formula (II).

    专利号:WO-2013091696-A1
    优先权日:2011-12-21
    标题 :Synthesis of intermediates for preparing anacetrapib and derivatives thereof
    发明人:HUMLJAN JAN; MARAS NENAD
    权利人:LEK PHARMACEUTICALS; HUMLJAN JAN; MARAS NENAD
    摘要:The present invention relates to the field of organic chemistry, more specifically to the synthesis of intermediate compounds which can be used in the synthesis of pharmaceutically active agents such as anacetrapib or derivatives thereof.
    宁波斯迈克制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.smart-pharm.com
    企业联系电话:0574-86221816👤
    📞宁波斯迈克制药有限公司 ⚠️参考联系方式
    联系人:张海波
    电话:0574-86221816
    手机:13957841334
    传真:0574-86222227
    邮箱:smart@smart-pharm.com;carolyn@smart-pharm.com
    通信地址: 浙江省宁波市北仑区小港镇义成路1号
    邮编: 315803
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省宁波市北仑区小港镇义成路1号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知